{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:53:49Z","timestamp":1793656429567,"version":"4.5.1"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.22241","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T15:31:10Z","timestamp":1657899070000},"page":"e2222241","source":"Crossref","is-referenced-by-count":49,"title":["Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US"],"prefix":"10.1001","volume":"5","author":[{"given":"Anne M.","family":"Hause","sequence":"first","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bicheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yue","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Marquez","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya R.","family":"Myers","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Parker","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Gee","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Su","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Shay","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"issue":"45","key":"zoi220633r1","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.15585\/mmwr.mm7045e1","article-title":"The Advisory Committee on Immunization Practices\u2019 interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years - United States, November 2021.","volume":"70","author":"Woodworth","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"zoi220633r6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7005a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 influenza season.","volume":"70","author":"Grohskopf","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"10318","key":"zoi220633r8","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/S0140-6736(21)02329-1","article-title":"Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.","volume":"398","author":"Lazarus","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"zoi220633r9","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/infdis\/jix481","article-title":"Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine coadministered with seasonal influenza vaccine in adults aged 50 years or older.","volume":"216","author":"Schwarz","year":"2017","journal-title":"J Infect Dis"},{"issue":"2","key":"zoi220633r10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1086\/599174","article-title":"Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.","volume":"200","author":"Falsey","year":"2009","journal-title":"J Infect Dis"},{"key":"zoi220633r2","unstructured":"Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. US Department of Health and Human Services, CDC; 2021. Accessed November 23, 2021. https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html"},{"key":"zoi220633r3","unstructured":"US Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine letter of authorization. US Food and Drug Administration; 2021. Accessed November 23, 2021. https:\/\/www.fda.gov\/media\/150386\/download"},{"key":"zoi220633r4","unstructured":"US Food and Drug Administration. Moderna COVID-19 vaccine letter of authorization. US Food and Drug Administration; 2021. Accessed November 23, 2021. https:\/\/www.fda.gov\/media\/144636\/download"},{"key":"zoi220633r5","unstructured":"US Food and Drug Administration. Janssen COVID-19 vaccine letter of authorization. US Food and Drug Administration; 2021. Accessed November 23, 2021. https:\/\/www.fda.gov\/media\/146303\/download"},{"key":"zoi220633r7","unstructured":"Centers for Disease Control and Prevention. v-safe after vaccination health checker. Accessed Jun 13, 2022. https:\/\/vsafe.cdc.gov\/en\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2794318\/hause_2022_oi_220633_1657548416.20984.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T15:31:21Z","timestamp":1657899081000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2794318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.22241","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]}}}